The results of this week’s poll about Medicare cap extension.
The results are in and 75% of our readers think the Medicare $2,000 per-year cap on out-of-pocket costs for prescription drugs should not be extended to commercial insurance.
A $3,250 cap went into effect this year and will be lowered to $2,000 next year. At this time, it only applies to Medicare enrollees with Part D coverage.
We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answer and post the results on Friday.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen